Navigation Links
MS Drug Helps Reduce Vision Loss

A drug that slows disability and reduces relapse rates in multiple sclerosis (MS) has been found to also reduce vision loss in patients with relapsing MS. //Vision loss is one of the most common and debilitating symptoms of MS. The findings are published in the April 17, 2007, issue of Neurology?, the scientific journal of the American Academy of Neurology.

The analyses were performed on data from the AFFIRM and SENTINEL studies, which involved 2,138 men and women with relapsing multiple sclerosis from clinics in Europe, North American, Australia, and New Zealand. More than half of the people received the drug natalizumab every four weeks for two years. The rest of the group received placebo. Researchers used eye charts of low contrast letters to test the vision of the participants every 12 weeks.

The study found vision loss, defined as a worsening in score by two rows of letters on the eye chart, was reduced by as much as 47 percent among people taking natalizumab compared to those taking placebo.

"Not only does natalizumab prevent the worsening of vision loss in people with relapsing MS, we also found the drug was associated with significant reductions in the likelihood of sustained vision loss," said study author Laura J. Balcer, MD, MSCE, with the University of Pennsylvania School of Medicine in Philadelphia, PA, and member of the American Academy of Neurology. "Specifically, this drug may have implications for preventing further sustained vision loss due to inflammatory demyelination of nerve fibers that connect to the eye, which is common in MS."

However, Balcer said the potential benefits of natalizumab treatment must be weighed with the drug's potential risks or complications, including the rare, often lethal brain disease progressive multifocal leukoencephalopathy (PML), of which three confirmed cases have been reported.

In addition, data from AFFIRM and SENTINEL studies showed that low-contrast le tter acuity eye chart testing is effective for assessing visual outcomes in future MS clinical trials, which have not typically included visual testing components despite vision loss being a main disability of MS.

Source-Eurekalert/L
'"/>




Related medicine news :

1. Antibiotics Helps Autism
2. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
3. Prescription Drug - Helps People Stop Smoking
4. New Drug PP188 Helps Sickle Cell Disease
5. Red Wine Helps Fight Heart disease
6. Creatine Helps Strengthen Older Men
7. Cholesterol Drug Helps After Angioplasty
8. Virus Helps Remove Brain Cancer
9. Eating Fish Helps the Heart
10. Antidepressant Helps Relieve Hot Flashes
11. Epilepsy Drug Helps Diabetic Nerve Damage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... , ... March 01, 2017 , ... ... healing grace in the lives of those who hear His voice. “Cleansing Thoughts; ... a retired Christian bookstore proprietor who enjoys boating, gardening and crocheting baby items ...
(Date:3/1/2017)... (PRWEB) , ... March 01, 2017 , ... “Our Pure Need of Obedience to the ... preparation for His return. “Our Pure Need of Obedience to the Law of God” is ... to attend missionary school. He and his wife, Anika, and children have since dedicated their ...
(Date:2/28/2017)... ... ... e-Zest Solutions ( http://www.e-zest.com ) – Digital Transformation leader ... intelligent mobile platform that is enabling sales people at small businesses to Fortune ... users in mind unlike most enterprise software, to improve their productivity by making ...
(Date:2/28/2017)... ... February 28, 2017 , ... Many of the country’s top ... Solutions to Healthcare’s Greatest Challenges,” during Intalere’s 2017 Executive Forum, taking place March ... Forum assembles the best and brightest healthcare leaders to exchange experiences, expertise and ...
(Date:2/28/2017)... Baltimore, MD (PRWEB) , ... February 28, 2017 , ... ... Healthcare are co-hosting a Wellness Day on March 4, 2017 from 10:00 a.m. to ... San Mateo and Menaul Blvds. , The goal of the Wellness Day is to ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... , March 1, 2017 The global  Intraoperative Neuromonitoring ... a new report by Grand View Research, Inc. The intraoperative neuromonitoring market is ... to the hospitals adopting intraoperative monitoring in a wide spectrum of surgeries. ... ... Grand View Research Logo ...
(Date:2/28/2017)... -- Prefilled Syringes Market: Scope and Segmentation Download ... report provides a forecast and analysis of the ... levels. It provides historical data of 2015 along ... of revenue (US$ Mn) and volume (Bn Units). ... an outlook on prefilled syringes consumption globally. It ...
(Date:2/28/2017)... , Feb. 28, 2017 Persistence Market ... global dysphagia management market in a new publication ... Forecast 2016-2024." As the name suggests, we have ... geographical regions and on the basis of the ... assessment of the opportunities available to all the ...
Breaking Medicine Technology: